Why Datrixo?
As a holding firm, Datrixo owns a portfolio of biotech/ deep-tech companies. We launched and scale 2 venture clusters in high-growth bio-tech sectors.
Early-stage deep-tech opportunity in high-growth biotech sectors, but more de-risked in terms of product-market-fit in comparison with other early stage portfolios.
Very unlike other deep-tech companies, our companies work on real commercial progress. For us the real income is a proxy for a proof-of-concept of the deep-tech viability.
To access more info for accredited investors, please, apply to invest >
Datrixo is a holding firm. We scale the AI/biotech companies.
Who We Are?
Datrixo is a venture holding and a builder. The holding’ value increases when its portfolio’s value increases. All holding’s owners & investors can realize new profit by selling their equity at any moment as DRX.
Commercializing the AI
We focus on industries where application of AI is a key to enable solution for a large-scale market problem. Datrixo is able to prototype new solution fast. This is because our team has deep understanding of tech combined with hands-on experience in numerous projects building tech-based business solutions for clients.
The Process
We identify new opportunity & prototype solution. After it was successfully validated by the live market, we are ready to scale a new standalone company via acquisitions & arbitrage. Datrixo supports new company until it has secured outside investment or until its valuation has grown high enough to realize the profit.
Current Portfolio
Our “post-Covid” cohort includes companies that were incubated before the crisis, are at the post-prototype stage and ready for scale due to the increased demand. The companies will be positioned for further rounds of investment at higher valuations than the current nominal portfolio valuations.
Bio-Tech/ Life Sciences (The Portfolio is Open for Investment)
Former
Stealth Portfolio
Bio-Tech/ Life Sciences (Portfolio is Open for Investment)